Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk: A Population Study of 3.3 Million People
Schramm et al.
Circulation 2008;117:1945-1954.
ABSTRACT
| FULL TEXT
The Case for Treating Tobacco Dependence as a Chronic Disease
Steinberg et al.
ANN INTERN MED 2008;148:554-556.
ABSTRACT
| FULL TEXT
Factors Affecting Use of Insulin Pens by Patients With Type 2 Diabetes
Rubin and Peyrot
Diabetes Care 2008;31:430-432.
ABSTRACT
| FULL TEXT
Clinical Predictors of Disease Progression and Medication Initiation in Untreated Patients With Type 2 Diabetes and A1C Less Than 7%
Pani et al.
Diabetes Care 2008;31:386-390.
ABSTRACT
| FULL TEXT
Combined Therapy With Insulin Plus Oral Agents: Is There Any Advantage?: An argument in favor
Riddle
Diabetes Care 2008;31:S125-S130.
FULL TEXT
Natural History of Cardiovascular Disease in Patients With Diabetes: Role of hyperglycemia
Milicevic et al.
Diabetes Care 2008;31:S155-S160.
ABSTRACT
| FULL TEXT
Advancing Insulin Therapy in Type 2 Diabetes Previously Treated With Glargine Plus Oral Agents: Prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy
Rosenstock et al.
Diabetes Care 2008;31:20-25.
ABSTRACT
| FULL TEXT
Medication Taking and Diabetes: A Systematic Review of the Literature
Odegard and Capoccia
The Diabetes Educator 2007;33:1014-1029.
ABSTRACT
| FULL TEXT
Exploring the Substitution of Exenatide for Insulin in Patients With Type 2 Diabetes Treated With Insulin in Combination With Oral Antidiabetes Agents
Davis et al.
Diabetes Care 2007;30:2767-2772.
ABSTRACT
| FULL TEXT
Addition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes
Holman et al.
NEJM 2007;357:1716-1730.
ABSTRACT
| FULL TEXT
Effect of Initial Combination Therapy With Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, and Metformin on Glycemic Control in Patients With Type 2 Diabetes
Goldstein et al.
Diabetes Care 2007;30:1979-1987.
ABSTRACT
| FULL TEXT
Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial
Farmer et al.
BMJ 2007;335:132-132.
ABSTRACT
| FULL TEXT
Efficacy and Safety of Incretin Therapy in Type 2 Diabetes: Systematic Review and Meta-analysis
Amori et al.
JAMA 2007;298:194-206.
ABSTRACT
| FULL TEXT
Low-Dose Rosiglitazone in Patients With Insulin-Requiring Type 2 Diabetes
Hollander et al.
Arch Intern Med 2007;167:1284-1290.
ABSTRACT
| FULL TEXT
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Authors/Task Force Members et al.
Eur Heart J Suppl 2007;9:C3-C74.
FULL TEXT
The management of people with type 2 diabetes with hypoglycaemic agents in primary care: retrospective cohort study
Calvert et al.
Fam Pract 2007;24:224-229.
ABSTRACT
| FULL TEXT
New Treatments for Diabetes
Bloomgarden et al.
NEJM 2007;356:2219-2223.
FULL TEXT
Clinical Translation of "A Diabetes Outcome Progression Trial": ADOPT Appropriate Combination Oral Therapies in Type 2 Diabetes
Goldstein
J. Clin. Endocrinol. Metab. 2007;92:1226-1228.
FULL TEXT
Adding Insulin Glargine Versus Rosiglitazone: Health-related quality-of-life impact in type 2 diabetes
Vinik and Zhang
Diabetes Care 2007;30:795-800.
ABSTRACT
| FULL TEXT
Effects of Vildagliptin on Glucose Control Over 24 Weeks in Patients With Type 2 Diabetes Inadequately Controlled With Metformin
Bosi et al.
Diabetes Care 2007;30:890-895.
ABSTRACT
| FULL TEXT
A 74-Year-Old Woman With Diabetes
Abrahamson
JAMA 2007;297:196-204.
ABSTRACT
| FULL TEXT
Metabolic Diapause in Pancreatic beta-Cells Expressing a Gain-of-function Mutant of the Forkhead Protein Foxo1
Buteau et al.
J. Biol. Chem. 2007;282:287-293.
ABSTRACT
| FULL TEXT
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Authors/Task Force Members et al.
Eur Heart J 2007;28:88-136.
FULL TEXT
The Physiology of Incretin Hormones and the Basis for DPP-4 Inhibitors
McKennon and Campbell
The Diabetes Educator 2007;33:55-66.
ABSTRACT
| FULL TEXT
Rationale for Dipeptidyl Peptidase 4 Inhibitors: A New Class of Oral Agents for the Treatment of Type 2 Diabetes Mellitus
Campbell
The Annals of Pharmacotherapy 2007;41:51-60.
ABSTRACT
| FULL TEXT
Case Study 1: Exploring the Pharmacologic Agents for Treatment of Type 2 Diabetes
Martin
The Diabetes Educator 2007;33:6S-13S.
FULL TEXT
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
Kahn et al.
NEJM 2006;355:2427-2443.
ABSTRACT
| FULL TEXT
Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus.
Ceglia et al.
ANN INTERN MED 2006;145:665-675.
ABSTRACT
| FULL TEXT
Practical Review of Oral Antihyperglycemic Agents for Type 2 Diabetes Mellitus
Koski
The Diabetes Educator 2006;32:869-876.
ABSTRACT
| FULL TEXT
Effect of switching medically vulnerable patients with uncontrolled diabetes from isophane insulin human to insulin glargine.
Erickson et al.
Am J Health Syst Pharm 2006;63:1862-1871.
ABSTRACT
| FULL TEXT
Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus.
Ho et al.
Arch Intern Med 2006;166:1836-1841.
ABSTRACT
| FULL TEXT
An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Glibenclamide as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on Metformin
Barnett et al.
Diabetes Care 2006;29:1818-1825.
ABSTRACT
| FULL TEXT
The relative effect of self-management practices on glycaemic control in type 2 diabetic patients in Mexico
Garcia et al.
Chronic Illness 2006;2:77-85.
ABSTRACT
A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naive People With Type 2 Diabetes.
Hermansen et al.
Diabetes Care 2006;29:1269-1274.
ABSTRACT
| FULL TEXT
Structured Personal Diabetes Care in Primary Health Care Affects Only Women's HbA1c
Nielsen et al.
Diabetes Care 2006;29:963-969.
ABSTRACT
| FULL TEXT
Treatment Escalation and Rise in HbA1c Following Successful Initial Metformin Therapy.
Nichols et al.
Diabetes Care 2006;29:504-509.
ABSTRACT
| FULL TEXT
Triple Therapy in Type 2 Diabetes: Insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.
Rosenstock et al.
Diabetes Care 2006;29:554-559.
ABSTRACT
| FULL TEXT
Incretin-based therapies: a clinical need filled by unique metabolic effects.
Drucker
The Diabetes Educator 2006;32:65S-71S.
FULL TEXT
Challenges and strategies for moving patients to injectable medications.
Siminerio
The Diabetes Educator 2006;32:82S-90S.
FULL TEXT
Comparison of Weighted Performance Measurement and Dichotomous Thresholds for Glycemic Control in the Veterans Health Administration
Pogach et al.
Diabetes Care 2006;29:241-246.
ABSTRACT
| FULL TEXT
The Impact of Patient Preferences on the Cost-Effectiveness of Intensive Glucose Control in Older Patients With New-Onset Diabetes
Huang et al.
Diabetes Care 2006;29:259-264.
ABSTRACT
| FULL TEXT
JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice
Prepared by: British Cardiac Society, British Hype
Heart 2005;91:v1-v52.
FULL TEXT
Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes: A Randomized Trial
Heine et al.
ANN INTERN MED 2005;143:559-569.
ABSTRACT
| FULL TEXT
An Endocrinologist-Supported Intervention Aimed at Providers Improves Diabetes Management in a Primary Care Site: Improving Primary Care of African Americans with Diabetes (IPCAAD) 7
Phillips et al.
Diabetes Care 2005;28:2352-2360.
ABSTRACT
| FULL TEXT
PRESERVE-{beta}: Two-year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metformin
Gerich et al.
Diabetes Care 2005;28:2093-2099.
ABSTRACT
| FULL TEXT
Matrix Metalloproteinases Contribute to Insulin Insufficiency in Zucker Diabetic Fatty Rats
Zhou et al.
Diabetes 2005;54:2612-2619.
ABSTRACT
| FULL TEXT
Systematic Review and Meta-analysis of Short-Acting Insulin Analogues in Patients With Diabetes Mellitus
Plank et al.
Arch Intern Med 2005;165:1337-1344.
ABSTRACT
| FULL TEXT
Improvement of Glycemic Control in Subjects With Poorly Controlled Type 2 Diabetes: Comparison of two treatment algorithms using insulin glargine
Davies et al.
Diabetes Care 2005;28:1282-1288.
ABSTRACT
| FULL TEXT
Strategies for the prevention of type 2 diabetes and cardiovascular disease
Tuomilehto et al.
Eur Heart J Suppl 2005;7:D18-D22.
FULL TEXT
Overview of new and developing pharmacological treatments
Bailey
Eur Heart J Suppl 2005;7:D23-D26.
FULL TEXT
Basal Insulin Therapy in Type 2 Diabetes
Bethel and Feinglos
J Am Board Fam Med 2005;18:199-204.
ABSTRACT
| FULL TEXT
Glycemic Control Continues to Deteriorate After Sulfonylureas Are Added to Metformin Among Patients With Type 2 Diabetes
Cook et al.
Diabetes Care 2005;28:995-1000.
ABSTRACT
| FULL TEXT
Oral Agents for Type 2 Diabetes: An Update
Kimmel and Inzucchi
Clin. Diabetes 2005;23:64-76.
ABSTRACT
| FULL TEXT
A Real-World Approach to Insulin Therapy in Primary Care Practice
Hirsch et al.
Clin. Diabetes 2005;23:78-86.
FULL TEXT
Metabolic Syndrome and Risk of Restenosis in Patients Undergoing Percutaneous Coronary Intervention
Rana et al.
Diabetes Care 2005;28:873-877.
ABSTRACT
| FULL TEXT
Risk of Urinary Tract Infection and Asymptomatic Bacteriuria among Diabetic and Nondiabetic Postmenopausal Women
Boyko et al.
Am J Epidemiol 2005;161:557-564.
ABSTRACT
| FULL TEXT
Comparison of Pioglitazone and Gliclazide in Sustaining Glycemic Control Over 2 Years in Patients With Type 2 Diabetes
Tan et al.
Diabetes Care 2005;28:544-550.
ABSTRACT
| FULL TEXT
Clinical Inertia in Response to Inadequate Glycemic Control: Do specialists differ from primary care physicians?
Shah et al.
Diabetes Care 2005;28:600-606.
ABSTRACT
| FULL TEXT
A Reduced-Fat Diet and Aerobic Exercise in Japanese Americans With Impaired Glucose Tolerance Decreases Intra-Abdominal Fat and Improves Insulin Sensitivity but not {beta}-Cell Function
Carr et al.
Diabetes 2005;54:340-347.
ABSTRACT
| FULL TEXT
The High-Fat Diet-Fed Mouse: A Model for Studying Mechanisms and Treatment of Impaired Glucose Tolerance and Type 2 Diabetes
Winzell and Ahren
Diabetes 2004;53:S215-S219.
ABSTRACT
| FULL TEXT
Induction of Long-term Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients Is Associated With Improvement of {beta}-Cell Function
Li et al.
Diabetes Care 2004;27:2597-2602.
ABSTRACT
| FULL TEXT
Insulin Strategies for Type 2 Diabetes Mellitus
Vivian et al.
The Annals of Pharmacotherapy 2004;38:1916-1923.
ABSTRACT
| FULL TEXT
Medication Adherence and Associated Hemoglobin A1c in Type 2 Diabetes
Krapek et al.
The Annals of Pharmacotherapy 2004;38:1357-1362.
ABSTRACT
| FULL TEXT
Health-Related Social Disengagement in Elderly Diabetic Patients: Association with subsequent disability and survival
Kuo et al.
Diabetes Care 2004;27:1630-1637.
ABSTRACT
| FULL TEXT
Improving Efficacy of Diabetes Management Using Treatment Algorithms in a Mainly Hispanic Population
Fanning et al.
Diabetes Care 2004;27:1638-1646.
ABSTRACT
| FULL TEXT
Hospital Management of Hyperglycemia
Campbell and Braithwaite
Clin. Diabetes 2004;22:81-88.
FULL TEXT
Meta-Analysis of the Effect of Diabetes on Restenosis Rates Among Patients Receiving Coronary Angioplasty Stenting
Gilbert et al.
Diabetes Care 2004;27:990-994.
ABSTRACT
| FULL TEXT
The Relationship Between Literacy and Glycemic Control in a Diabetes Disease-Management Program
Rothman et al.
The Diabetes Educator 2004;30:263-273.
Oral Antidiabetic Agents: A Comparative Review
Koski
Journal of Pharmacy Practice 2004;17:39-48.
ABSTRACT
Glycemic Control From 1988 to 2000 Among U.S. Adults Diagnosed With Type 2 Diabetes: A preliminary report
Koro et al.
Diabetes Care 2004;27:17-20.
ABSTRACT
| FULL TEXT
One-Year Glycemic Control With a Sulfonylurea Plus Pioglitazone Versus a Sulfonylurea Plus Metformin in Patients With Type 2 Diabetes
Hanefeld et al.
Diabetes Care 2004;27:141-147.
ABSTRACT
| FULL TEXT
Pioglitazone preserves pancreatic islet structure and insulin secretory function in three murine models of type 2 diabetes
Diani et al.
Am. J. Physiol. Endocrinol. Metab. 2004;286:E116-E122.
ABSTRACT
| FULL TEXT
Prevention or Delay of Type 2 Diabetes
Diabetes Care 2004;27:s47-47.
FULL TEXT
Glucagon-Like Peptide-1 and the Islet {beta}-Cell: Augmentation of Cell Proliferation and Inhibition of Apoptosis
Drucker
Endocrinology 2003;144:5145-5148.
FULL TEXT
The Combined Effect of Triple Therapy With Rosiglitazone, Metformin, and Insulin Aspart in Type 2 Diabetic Patients
Poulsen et al.
Diabetes Care 2003;26:3273-3279.
ABSTRACT
| FULL TEXT
Early Combination Therapy With a Thiazolidinedione for the Treatment of Type 2 Diabetes
Kanzer-Lowis
The Diabetes Educator 2003;29:954-961.
The Treat-to-Target Trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
Riddle et al.
Diabetes Care 2003;26:3080-3086.
ABSTRACT
| FULL TEXT
Effects of Clinical Nutrition Education and Educator Discipline on Glycemic Control Outcomes in the Indian Health Service
Wilson et al.
Diabetes Care 2003;26:2500-2504.
ABSTRACT
| FULL TEXT
Insulin and Oral Hypoglycemic Agents Should Not Be Used in Combination in the Treatment of Type 2 Diabetes
Westphal and Palumbo
Arch Intern Med 2003;163:1783-1785.
FULL TEXT
Insulin 70/30 Mix Plus Metformin Versus Triple Oral Therapy in the Treatment of Type 2 Diabetes After Failure of Two Oral Drugs: Efficacy, safety, and cost analysis
Schwartz et al.
Diabetes Care 2003;26:2238-2243.
ABSTRACT
| FULL TEXT
Effect on Glycemic Control of Exenatide (Synthetic Exendin-4) Additive to Existing Metformin and/or Sulfonylurea Treatment in Patients With Type 2 Diabetes
Fineman et al.
Diabetes Care 2003;26:2370-2377.
ABSTRACT
| FULL TEXT
Prevention of Incipient Diabetic Nephropathy by High-Dose Thiamine and Benfotiamine
Babaei-Jadidi et al.
Diabetes 2003;52:2110-2120.
ABSTRACT
| FULL TEXT
Differential Adoption of Pharmacotherapy Recommendations for Type 2 Diabetes by Generalists and Specialists
Pugh et al.
Med Care Res Rev 2003;60:178-200.
ABSTRACT
Addition of Nateglinide to Rosiglitazone Monotherapy Suppresses Mealtime Hyperglycemia and Improves Overall Glycemic Control
Fonseca et al.
Diabetes Care 2003;26:1685-1690.
ABSTRACT
| FULL TEXT
Rapid Increase in the Use of Oral Antidiabetic Drugs in the United States, 1990-2001
Wysowski et al.
Diabetes Care 2003;26:1852-1855.
ABSTRACT
| FULL TEXT
Outpatient Insulin Therapy in Type 1 and Type 2 Diabetes Mellitus: Scientific Review
DeWitt and Hirsch
JAMA 2003;289:2254-2264.
ABSTRACT
| FULL TEXT
Acarbose Improves Glycemic Control in Overweight Type 2 Diabetic Patients Insufficiently Treated With Metformin
Phillips et al.
Diabetes Care 2003;26:269-273.
ABSTRACT
| FULL TEXT
Glucagon-Like Peptides: Regulators of Cell Proliferation, Differentiation, and Apoptosis
Drucker
Mol. Endocrinol. 2003;17:161-171.
ABSTRACT
| FULL TEXT
Cardiovascular Disease in Type 2 Diabetes Mellitus: Current Management Guidelines
Mooradian
Arch Intern Med 2003;163:33-40.
ABSTRACT
| FULL TEXT
The Prevention or Delay of Type 2 Diabetes
Diabetes Care 2003;26:s62-69.
FULL TEXT
Effect of Combination Glipizide GITS/Metformin on Fibrinolytic and Metabolic Parameters in Poorly Controlled Type 2 Diabetic Subjects
Cefalu et al.
Diabetes Care 2002;25:2123-2128.
ABSTRACT
| FULL TEXT
Counseling Patients With Type 2 Diabetes and Insulin Resistance in the Outpatient Setting
Campbell and White
The Diabetes Educator 2002;28:938-957.
Initial Management of Glycemia in Type 2 Diabetes Mellitus
Nathan
NEJM 2002;347:1342-1349.
FULL TEXT
Polypharmacy in Elderly Patients With Diabetes
Good
Diabetes Spectr. 2002;15:240-248.
ABSTRACT
| FULL TEXT
Comparison of Insulin Monotherapy and Combination Therapy With Insulin and Metformin or Insulin and Troglitazone in Type 2 Diabetes
Strowig et al.
Diabetes Care 2002;25:1691-1698.
ABSTRACT
| FULL TEXT
Treatment of Type 2 Diabetes: The American Association of Clinical Endocrinologists Meeting, May 2002
Bloomgarden
Diabetes Care 2002;25:1644-1649.
FULL TEXT
